Sandra Codony

Sandra Codony

Auto-generated profile, based on publicly available information

Sandra Codony

Laboratori de Química Farmacèutica Facultat de Farmàcia i Ciències de l’Alimentació Universitat de Barcelona Barcelona Spain

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2020 in Neurotherapeutics
Verified
Journal Article
Closed access
PDF file
Christian Griñán-FerréChristian Griñán-Ferré
Christian Griñán-Ferré
SCSandra Codony
Sandra Codony
EBEugènia Pujol Bech
Eugènia Pujol Bech
JYJun Yang
Jun Yang
RLRosana Leiva
Rosana Leiva
CGCarles Galdeano
Carles Galdeano

22 December 2017 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
RLRosana Leiva
Rosana Leiva
Marta Barniol-XicotaMarta Barniol-Xicota
Marta Barniol-Xicota
SCSandra Codony
Sandra Codony
TGTiziana Ginex
Tiziana Ginex
EVEvelien Vanderlinden
Evelien Vanderlinden
Santiago VazquezSantiago Vazquez
Santiago Vazquez

1 October 2019 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
SCSandra Codony
Sandra Codony
EVElena Valverde
Elena Valverde
RLRosana Leiva
Rosana Leiva
JBJose Brea
Jose Brea
MLM. Isabel Loza
M. Isabel Loza
Santiago VazquezSantiago Vazquez
Santiago Vazquez

16 May 2018 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
JAJosé M. Alonso
José M. Alonso
SQSabela Quiroga
Sabela Quiroga
SCSandra Codony
Sandra Codony
ATANDREEA LARISA TURCU
ANDREEA LARISA TURCU
Marta Barniol-XicotaMarta Barniol-Xicota
Marta Barniol-Xicota
DPDiego Peña
Diego Peña
The metal-catalyzed [2+2+2] cocycloaddition of arynes with pyramidalized alkenes is presented. The generation of a highly reactive pyramidalized alkene in the presence of a large excess of in situ-produced arynes led to the corresponding cocyclotrimerization (1 : 2)-adducts in good yields, establishing the first example of a palladium-based reaction of a pyramidalized alkene.

1 April 2014 in Tetrahedron Letters
Verified
Journal Article
Closed access
Marta Barniol-XicotaMarta Barniol-Xicota
Marta Barniol-Xicota
ATANDREEA LARISA TURCU
ANDREEA LARISA TURCU
SCSandra Codony
Sandra Codony
CECarmen Escolano
Carmen Escolano
Santiago VazquezSantiago Vazquez
Santiago Vazquez

23 October 2025 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Open access
SCSandra Codony
Sandra Codony
BJBeatrice Jora
Beatrice Jora
MSMiriam Santos-Caballero
Miriam Santos-Caballero
QQQiongju Qiu
Qiongju Qiu
CCCarla Calvó-Tusell
Carla Calvó-Tusell
Santiago VazquezSantiago Vazquez
Santiago Vazquez
The soluble epoxide hydrolase (sEH) has recently emerged as a promising target for the treatment of several pain-related conditions. Herein, we report the design and synthesis of a peripherally restricted sEH inhibitor with high potency and good Drug Metabolism and Pharmacokinetics (DMPK) properties. Molecular dynamics and X-ray crystallography helped reveal the binding of these inhibitors to sEH. The selected compound showed a robust analgesic effect in a dose-dependent manner in a murine model of chemotherapy-induced neuropathic pain (CINP). Moreover, the compound also prevented the development of paclitaxel-induced neuropathic pain. Overall, these results suggest that peripheral inhibition of sEH might constitute a novel therapy to prevent and treat CINP.